Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 21 | 26 | 25 | 16 | 45 |
| Cost of Goods | 40 | 68 | 10 | 10 | 7 |
| Gross Profit | -19 | -42 | 15 | 6 | 38 |
| Operating Expenses | 2,973 | 2,473 | 2,671 | 3,635 | 5,900 |
| Operating Income | -2,952 | -2,447 | -2,646 | -3,619 | -5,855 |
| Interest Expense | 391 | 148 | 149 | 124 | 132 |
| Other Income | -832 | -689 | 1 | 38 | 20 |
| Pre-tax Income | -4,175 | -3,284 | -2,794 | -3,705 | -5,967 |
| Net Income Continuous | -4,175 | -3,284 | -2,794 | -3,705 | -5,967 |
| Net Income | $-4,175 | $-3,284 | $-2,794 | $-3,705 | $-5,967 |
| EPS Basic Total Ops | 1.63 | -1.57 | -3.68 | -5.00 | -9.92 |
| EPS Basic Continuous Ops | 1.89 | -1.57 | -3.68 | -5.27 | -9.27 |
| EPS Diluted Total Ops | 1.63 | -1.57 | -3.68 | -5.00 | -9.92 |
| EPS Diluted Continuous Ops | 1.89 | -1.57 | -3.68 | -5.27 | -9.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.32 | -3.68 | -5.00 | -10.00 |
| EBITDA(a) | $-2,168 | $-2,242 | $-2,192 | $-3,162 | $-5,720 |